Genetically Modified Non-Human Animals and Methods of Use Thereof
Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12127537 B2, initially filed May 10, 2021) developed by eight inventors Richard Flavell, Guilford, Connecticut; Markus Manz, Zollikon, Switzerland; Anthony Rongvaux, New Haven, Connecticut; Till Strowig, Braunschweig, Germany; Tim Willinger, Ultran, Sweden; Andrew J. Murphy, Croton-on-Hudson, New York; Sean Stevens, Del Mar, California; and George Yancopoulos, Yorktown Height . . .